Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX)
CUSIP: 45720N103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 14,560,641
- Total 13F shares
- 8,897,409
- Share change
- -793,966
- Total reported value
- $139,328,871
- Put/Call ratio
- 35%
- Price per share
- $15.66
- Number of holders
- 95
- Value change
- -$10,813,194
- Number of buys
- 53
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 45720N103?
CUSIP 45720N103 identifies INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45720N103:
Top shareholders of INBX - Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
12%
|
1,787,705
|
$25,331,780 | — | 30 Jun 2024 | |
| Mark P. Lappe |
3/4/5
13D/G
|
Chief Executive Officer, Director · Mark Lappe |
6.4%
from 13D/G
|
1,225,413
mixed-class rows
|
$15,852,324 | — | 12 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
7.3%
|
1,064,026
|
$15,077,248 | — | 30 Jun 2024 | |
| Jon Faiz Kayyem |
13D/G
|
— |
7.9%
|
1,149,046
|
$13,765,571 | $0 | 03 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.7%
|
683,075
|
$9,679,169 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
478,028
|
$6,773,658 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
3.3%
|
474,999
|
$6,730,736 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.2%
|
463,315
|
$6,565,174 | — | 30 Jun 2024 | |
| Brendan P. Eckelman |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
648,888
mixed-class rows
|
$6,127,372 | — | 29 May 2024 | |
| Slotnik Capital, LLC |
13F
|
Company |
2.3%
|
341,605
|
$4,840,543 | — | 30 Jun 2024 | |
| ALPINE ASSOCIATES MANAGEMENT INC. |
13F
|
Company |
2.1%
|
305,967
|
$4,335,552 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
303,196
|
$4,296,287 | — | 30 Jun 2024 | |
| TIG Advisors, LLC |
13F
|
Company |
1.7%
|
243,650
|
$3,452,520 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
235,916
|
$3,342,930 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.6%
|
230,000
|
$3,259,099 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
210,317
|
$2,980,524 | — | 30 Jun 2024 | |
| Caption Management, LLC |
13F
|
Company |
1.4%
|
199,998
|
$2,833,972 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
197,500
|
$2,798,575 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
167,500
|
$2,373,475 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
164,971
|
$2,337,639 | — | 30 Jun 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1%
|
152,159
|
$2,156,093 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
148,586
|
$2,105,464 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.97%
|
141,400
|
$2,003,638 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.93%
|
135,546
|
$1,920,687 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.88%
|
127,500
|
$1,806,675 | — | 30 Jun 2024 | |
| MMCAP International Inc. SPC |
13F
|
Company |
0.78%
|
112,858
|
$1,599,198 | — | 30 Jun 2024 | |
| CSS LLC/IL |
13F
|
Company |
0.76%
|
110,651
|
$1,567,924 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.74%
|
107,500
|
$1,523,000 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.71%
|
102,761
|
$1,456,123 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.61%
|
88,470
|
$1,253,620 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
81,112
|
$1,149,357 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.52%
|
75,980
|
$1,076,635 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
74,068
|
$1,049,544 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.48%
|
70,564
|
$999,891 | — | 30 Jun 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
—
class O/S missing
|
26,400
|
$928,000 | — | 30 Jun 2024 | |
| Westchester Capital Management, LLC |
13F
|
Company |
0.44%
|
64,339
|
$911,683 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
44,265
|
$627,235 | — | 30 Jun 2024 | |
| BLUEFIN CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
33,275
|
$471,507 | — | 30 Jun 2024 | |
| Laird Norton Wetherby Wealth Management, LLC |
13F
|
Company |
0.22%
|
32,682
|
$463,104 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.22%
|
31,678
|
$448,878 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
31,326
|
$443,889 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.19%
|
28,229
|
$400,007 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
26,772
|
$379,359 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.16%
|
23,232
|
$329,000 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.16%
|
22,577
|
$319,916 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.15%
|
21,386
|
$303,040 | — | 30 Jun 2024 | |
| JBF Capital, Inc. |
13F
|
Company |
0.14%
|
20,949
|
$296,847 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
20,705
|
$293,389 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.13%
|
19,210
|
$272,206 | — | 30 Jun 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.13%
|
18,263
|
$258,787 | — | 30 Jun 2024 |
Institutional Holders of Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX) as of Q3 2024
As of 30 Sep 2024,
Inhibrx Biosciences, Inc. - Common Stock, par value $0.0001 per share (INBX) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,897,409 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., Walleye Capital LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, Slotnik Capital, LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
95
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
86
Q3 2024 holders
95
Holder diff
9
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.